The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
Cucurbitacin B (CuB) is one of the potential agents for long term anticancer chemoprevention.Cumulative evidences has shown that cucurbitacin B provides potent cellular biological activities such as hepatoprotective, anti-inflammatory and antimicrobial effects, but the precise mechanism of Whiteline this agent is not clearly understood.We examine t